Frontlight ResearchEarly access
Trial site
Yuma Regional Medical Center
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Immune thrombocytopenia (ITP)2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 25 trials
- Phase 33 trials
- Phase 2/32 trials
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals2 trials
- Regeneron Pharmaceuticals2 trials
- Aadi Bioscience, Inc.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Janssen Research & Development, LLC1 trial
- and 4 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026